Figure 4From: A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgiaLS mean pain VAS score. Weekly assessment analyses based on the results of the MMRM analysis with weekly mean VAS score. Scores range from 0 to 100 with higher scores indicating increased pain. Mean value (± SE) shown for each time point, where *P ≤0.025, **P ≤0.001 and ***P ≤0.0001 for each treatment time point compared with placebo.Back to article page